Cystic Fibrosis
Colleagues across our Schools and Faculties are dedicated to deepening our understanding of diseases and developing solutions and treatments for them. Our expertise in conducting clinical trials and our world leading facilities in cancer and precision medicine research are a testament to the breakthroughs that Queen’s research has facilitated over the decades. We are also leading the way in developing strategies and initiatives which mitigate against the worst effects of illness, and which act as preventative agents to illnesses developing in the first place. A strong public health approach, focusing on community well-being, aligned with a commitment to social justice drives our pledge to improve health outcomes which can reduce inequalities across society.
How we’re delivering:
Researchers from Queen’s have transformed the lives of thousands of people with Cystic Fibrosis by leading on the clinical development of treatments. We’re supporting cancer care for patients and families through the development of a new model for follow up care termed ‘The Recovery Package’ and we are developing internationally-recognised expertise in the genetics and treatment of age-related macular degeneration (AMD).
To address the many challenges faced by healthcare services, researchers at Queen's University are pioneering new statistical models and data analysis techniques. This crucial research can contribute both to the effective management of the UK’s healthcare system and its ability to cope with future epidemics and pandemics.